第一范文网 - 专业文章范例文档资料分享平台

TY-52156 - LPL Receptor Antagonist- MedChemExpress

来源:用户分享 时间:2025/5/24 23:28:37 本文由loading 分享 下载这篇文档手机版
说明:文章内容仅供预览,部分内容可能不全,需要完整文档或者需要复制内容,请下载word后使用。下载word有问题请添加微信号:xxxxxxx或QQ:xxxxxx 处理(尽可能给您提供完整文档),感谢您的支持与谅解。

Hotline: 400-820-3792

Inhibitors?Agonists?Screening Librarieswww.MedChemExpress.cnTY-52156Cat. No.:CAS No.:HY-19736934369-14-9C??H??Cl?N?O364.27LPL ReceptorGPCR/G ProteinPowder-20°C4°CIn solvent-80°C-20°C3 years2 years6 months1 month分?式:分?量:作?靶点:作?通路:储存?式:溶解性数据体外实验DMSO : ≥ 100 mg/mL (274.52 mM)H2O : < 0.1 mg/mL (insoluble)* \Mass1 mg2.7452 mL0.5490 mL0.2745 mL5 mg13.7261 mL2.7452 mL1.3726 mL10 mg27.4522 mL5.4904 mL2.7452 mLSolventConcentration制备储备液1 mM5 mM10 mM请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存?式和期限。体内实验请根据您的实验动物和给药?式选择适当的溶解?案,配制前请先配制澄清的储备液,再依次添加助溶剂 (为保证实验结果的可靠性,体内实验的?作液,建议您现?现配,当天使?;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分?是指该溶剂在您配制终溶液中的体积占?):1.请依序添加每种溶剂: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline Solubility: ≥ 2.5 mg/mL (6.86 mM); Clear solution BIOLOGICAL ACTIVITY1/2

Master of Small Molecules —您?边的抑制剂?师

www.MedChemExpress.cn

?物活性IC50 & TargetTY-52156 是?种有效、选择性的 S1P3 受体拮抗剂,Ki 值为 110 nM [1]。Ki: 110 nM (S1P3) [1]TY-52156 inhibits the S1P3 receptor-dependent increase in [Ca2+]i [1]. TY-52156 shows submicromolar potency and a high degree of selectivity for S1P3 receptor [1]. TY-52156 (10 μM; 10 min) inhibits S1P-induced p44/p42 MAPK phosphorylation [1]. Western Blot Analysis [1]Cell Line:Concentration:Incubation Time:Result:Chinese hamster ovary K1 cells10 μM10 minInhibited S1P-induced p44/p42 MAPK phosphorylation.体外研究体内研究TY-52156 (10 mg/kg, 30 mg/kg; p.o.) suppresses S1P3 receptor-induced bradycardia after oral administration in vivo [1]. Animal Model:Dosage:Administration:Result:Male SD rats (290–340 g) [1]10 mg/kg, 30 mg/kgOral administrationInhibited S1P3 receptor-induced bradycardia after oral administration in vivo. 客户使?本产品发表的科研?献? EBioMedicine. 2019 Feb;40:210-223.? Oncogene. 2017 Jun 29;36(26):3760-3771.? Exp Ther Med. 2018 Jun;15(6):5007-5016.See more customer validations on www.MedChemExpress.cn REFERENCES[1]. Murakami A, et al. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. Mol Pharmacol. 2010 Apr;77(4):704-13.McePdfHeightCaution: Product has not been fully validated for medical applications. For research use only.

Tel: 400-820-3792; 021-58955995

Fax: 021-53700325

E-mail: tech@MedChemExpress.cn

2/2Master of Small Molecules —您?边的抑制剂?师

搜索更多关于: TY-52156 - LPL Receptor Antag 的文档
TY-52156 - LPL Receptor Antagonist- MedChemExpress.doc 将本文的Word文档下载到电脑,方便复制、编辑、收藏和打印
本文链接:https://www.diyifanwen.net/c6v6yo2v2ev79c964hjsm5kaxd91bpl00kta_1.html(转载请注明文章来源)
热门推荐
Copyright © 2012-2023 第一范文网 版权所有 免责声明 | 联系我们
声明 :本网站尊重并保护知识产权,根据《信息网络传播权保护条例》,如果我们转载的作品侵犯了您的权利,请在一个月内通知我们,我们会及时删除。
客服QQ:xxxxxx 邮箱:xxxxxx@qq.com
渝ICP备2023013149号
Top